Changing Diabetes® 

Driving change to defeat diabetes

At Novo Nordisk, we are driven by a core belief: that the alarming rise of diabetes is not inevitable. We can change its trajectory - and we must act now.

Click here to read more

Structured approach to ethical business

Each day, Novo Nordisk employees bring ethical standards to work.

Click here to read more

Report a complaint or side effect

Your information about complaints and side effects helps us ensure the safety of our products.

How to report a complaint or side effect

Urgent Medical Device Recall - NovoPen® Echo®

Novo Nordisk is exchanging the cartridge holder for certain batches in Australia and New Zealand to protect patient safety.

Read more here

Product Information

Written principally for Healthcare Professionals, the Product Information documents provide prescribing information for each of our products. To access the documents click here

Scam Alert

Novo Nordisk has been alerted to a potential scam, involving the phishing of personal information in exchange for an offer of paid promotional activity with Novo Nordisk. It is important to note that Novo Nordisk has no connection to these fraudulent activities and at no time would request personal information such as passwords, etc.  The scam has so far been seen on Facebook – and appears on a number of Job related forums, from a variety of posters.  Read more here

We offer 0 job opportunities


Medicines Australia Transparency Reports

Please click here to access the reports.

Contact Us

Novo Nordisk Pharmaceuticals Pty. Ltd.
PO Box 7586
Baulkham Hills Business Centre NSW 2153
ABN 40 002 879 996
Tel: 1800 224 321
Fax: +61 2 8858 3799

Media Enquiries:
Mark Gibson, Director
Market Access & Public Affairs
Tel: +61 408 200 523

NovoCare® Customer Care Centre:
 1800 668 626
Fax: +61 2 8858 3799

NordiCare® Hotline:
 1800 632 362
Fax: +61 2 8858 3799

Wholesaler orders - email
Novoseven®RT orders - email
Norditropin® Orders- email

Page Updated December 2017